(secondQuint)Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens.

 A prospective, single-phase, non-randomized, open-label study to include patients with operable cataract of the human crystalline lens who have a potential post-operative best corrected visual acuity of 20/40 or better and no pre-existing progressive sight-threatening ocular disorders.

 Patients who are eligible per inclusion / exclusion criteria will undergo phacoemulsification cataract extraction and then implantation of the Hoya HMY Model YA-60BB posterior chamber intraocular lens.

 Each patient will be followed-up at specific time intervals to assess safety and effectiveness, for up to 36 months.

.

 Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens@highlight

The purpose of this study is to assess the safety and efficacy of the HMY Model YA-60BB Intraocular Lens (IOL) when implanted in the posterior chamber of the human eye for the optical correction of aphakia following cataract extraction.

